Skip to content
Search

Latest Stories

NHS to receive extra £33.9 billion every year by 2024

The government has announced that the NHS Long Term Plan Funding Bill will enshrine in law an extra £33.9 billion a year by 2024.

The bill, which will be introduced by Secretary of State for Health and Social Care Matt Hancock to the Parliament today, will include a ‘double-lock’ commitment that places a legal duty on the government to guarantee a minimum level of spending every year, rising to £148.5 billion over the next four years.


It will not seek to limit the NHS in deciding how funding is spent and where.

Outlining his government's commitment to the NHS, Prime Minister Boris Johnson said: "Putting our record funding commitment into laws shows that we will stop at nothing to deliver on the people’s priorities."

“Guaranteeing frontline services the biggest cash boost in history is another huge step towards making sure this treasured institution has everything it needs to deliver world-class care,” he added.

The NHS funding bill is one of the first pieces of domestic legislation to go through Parliament since the new government took office.

Matt Hancock said: “During the election campaign, we committed to boosting funding for our NHS over the course of the Parliament and ensuring these new resources get to the frontline so that patients receive the care they need.

“With this unprecedented bill, we will enshrine in law the largest cash settlement in NHS history – bringing the total annual budget to almost £150 billion within five years.”

The bill provides safeguards that mean the Treasury will be required to ensure the annual supply estimates for the department’s NHS budget cannot be reduced.

Expressing his commitment to the bill, the Chancellor of the Exchequer, Sajid Javid, said: "We are delivering on our promise to focus on the people’s priorities, with the NHS at the forefront. By enshrining the largest ever cash increase for the NHS in law, we will deliver a world-class health service that makes life in this country even better for people."

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less